Abstract: An immunotherapy method of targeted chemokine and cytokine delivery by a mesenchymal stem cell that expresses an immunostimulatory factor. The immunostimulatory factor is selected from the following group: CCL3, CCL19, CCL21, XCL1, CXCL9, OX40L, 4-1BBL, GITRL, CD40L, or a combination thereof. At a tumor site, the mesenchymal stem cell specifically attracts and activates an immune cell that kills tumor tissue, and the mesenchymal stem cell has a synergistic effect with chemokines and/or cytokines, having an immunotherapeutic effect with higher efficiency and few side effects, and a significantly enhanced ability to kill tumor tissue, especially colorectal cancer cells.

Abstract: Provided are organometallic compounds comprising a central metal ion which is coordinated by an at least two-dentate ligand comprising at least two 5-membered to 10-membered carbocyclic or heterocyclic rings and further at least one four-membered diene-ring. Also provided are formulations comprising these organometallic compounds. Further provided are organic light-emitting devices (OLEDs) as well as related consumer products that utilize these organometallic compounds.

Abstract: Provided are organometallic compounds comprising a central metal atom which is coordinated by an at least two-dentate ligand comprising at least two 5-membered to 10-membered carbocyclic or heterocyclic rings. Also provided are formulations comprising these organometallic compounds. Further provided are organic light emitting devices (OLEDs) as well as related consumer products that utilize these organometallic compounds.

Abstract: An electric toilet seat lift, including toilet seat, bracket, lift support configurable to control the toilet seat to be raised and lowered, and drive configurable to drive the lift support to move, drive including a linear actuator and an adjuster module, one end of the linear actuator being hinged to the lift support, an opposite end thereof being hinged to adjuster module, adjuster module being configurable to drive positional change of an end portion of the linear actuator and including a pivot connector assembly hinged to the end portion of the linear actuator and a pivot pusher assembly configurable to drive the pivot connector assembly to move. The electric toilet seat lift as disclosed realizes change of the seat trajectory through positional adjustment of the end portion of the linear actuator, satisfies requirements of various heights of users for a same toilet, and offers a higher degree of general-purpose utility.

Abstract: A method of controlling a vehicle member to perform an operation includes, in response to a vehicle turning on an interaction mode according to a music scene, generating a control instruction used to control the vehicle member based on at least one of music information in the music scene or motion information of a person outside the vehicle, and based on the control instruction, controlling the vehicle member to perform the corresponding operation.

Abstract: The present invention relates in part to compounds containing indolocarbazole and terphenyl building blocks are disclosed in this application. These compounds are useful for application in organic electroluminescent devices wherein the combination of indolocarbazoles with terphenyl groups leads to novel compounds that demonstrate superior device performance.

Abstract: Provided are fused-indole containing compounds which contain as a further structural unit at least one of pyrimidine, triazine, quinazoline, benzene, biphenyl, terphenyl, naphthalene, phenanthrene, anthracene, triphenylene, pyridine, pyrazine, fluorene, dibenzofuran, dibenzothiophene, carbazole, quinoline, isoquinoline, triarylboryl or quinoxaline, which may be further substituted. Also provided are formulations comprising these compounds. Further provided are OLEDs and related consumer products that utilize these compounds.

Abstract: A compound having a structure of Formula I, provided. In Formula I, each of R1 to R7 is hydrogen or phenyl or a system consisting of two to ten phenyl groups connected to each other; at least two of R1 to R7 are not hydrogen; each of R8 and R9 are phenyl or a system consisting of two to ten phenyl groups connected to each other; X is O, S, or Se; and L is a direct bond or In the structure of L, m is an integer from 1 to 5, and RA is hydrogen, an aromatic or a heteroaromatic ring. Formulations, OLEDs, and consumer products containing the same are also provided.

Abstract: Novel compounds useful as hosts in OLEDs having Formula I is disclosed.

Abstract: A method and an electronic device for handling a material are provided. The method may include: obtaining a picking task for a target material at a target warehouse; using, in response to determining that a target person arrives at an exit location of the target warehouse, material information of a material held by the target person as target material information, the material information including a material identifier and a material quantity; and comparing material information of a to-be-picked material in the picking task with the target material information, and subtracting the material information of the to-be-picked material from stock information of the target warehouse if a comparison result is that the material information and the target material information are consistent.

Abstract: A first device including a first organic light emitting device is provided. The first OLED includes an anode; a cathode; and a first emissive layer, disposed between the anode and the cathode, comprising a first emissive dopant that is a phosphorescent metal compound having an emission peak wavelength between 530 nm to 580 nm. The first device also includes a second emissive layer that includes a fluorescent compound, a phosphorescent compound, or both; and the first device is capable of emitting white light.

Abstract: A compound, Ir(LA)m(LB)3-m, having a structure of Formula I, ?is provided. In Formula I, each of moiety A and moiety C is independently a 5- or 6-membered ring or a polycyclic fused ring system comprising 5- or 6-membered rings; moiety B is a 5-membered heterocyclic ring; Z1, Z2, and Z3 are C or N; m is 1 or 2; at least one of R1, R2, R3, R4 has a structure of Formula II, ?or is a 5-membered heterocyclic ring; each of X1, X2, X3, X4, and X5 is CR or N; each of R1, R2, R3, R4, RA, RB, RC, and R is hydrogen or a General Substituent; at least one of R1a, R2a, R3a, R4a, R5a is cycloalkyl, alkyl, silyl, germyl, deuterated variants thereof, fluorinated variants thereof, and combinations thereof. Formulations, OLEDs, and consumer products containing the compound are also provided.

Abstract: Provided are new compositions of matter for host materials in OLEDs by incorporating deuterated moieties in the organic molecules. Also provided are formulations comprising these deuterated compounds. Further provided are OLEDs and related consumer products that utilize these deuterated compounds.

Abstract: The present disclosure provides for an organic electroluminescent device (OLED) including an anode; a cathode; and an emissive layer, disposed between the anode and the cathode. The emissive layer includes a phosphorescent dopant, a first host, and a second host, wherein the first host transports holes, the second host transports electrons, and the first host is fully or partially deuterated. Consumer products that include the OLED are also provided.

Abstract: All example composition may include a plurality of grains including an iron nitride phase. The plurality of grains may have an average wain size between about 10 nm and about 200 nm. An example technique may include treating a composition including a plurality of grains including au iron-based phase to adjust an average grain size of the plurality of grains to between about 20 nm and about 100 ma. The example technique may include nitriding the plurality of grains to form or grow an iron nitride phase.

Abstract: Provided are compounds of the Formula (I); or pharmaceutically acceptable salts thereof, which can be useful for the inhibition of Drp 1 and in the treatment of a variety of Drp 11 mediated conditions or diseases.

Abstract: A method for increasing peptide fragmentation by labelling the peptide at the C-terminal end with a guanidinium group or other basic functional group and distinguishing isobaric amino acids and amino acid combinations of asparagine and glycine-glycine; glutamine and glycine-alanine; and/or glutamine and alanine-glycine, during polypeptide sequencing.

Abstract: A phosphatidylamine compound including a plurality of tertiary amino group structures and the composition thereof are provided. The phosphatidylamine compound is a phospholipid compound including two or more tertiary amino group structures, the structure of which is represented by the following formula (I). The compound works together with other lipid components such as cholesterol, DSPC/DOPE, DMG-PEG2000, and other helper lipids to form lipid nanoparticles (LNPs), which may be used for efficient delivery of drug molecules such as nucleic acids (siRNA, mRNA, pDNA), thereby realizing diagnosis and treatment of diseases such as cancer, fibrosis (e.g., liver, lung, kidney).

Abstract: The present disclosure provides for an organic electroluminescent device (OLED) including an anode; a cathode; and an emissive layer, disposed between the anode and the cathode. The emissive layer includes a phosphorescent dopant, a first host, and a second host, wherein the first host transports holes, the second host transports electrons, and the first host is fully or partially deuterated. Consumer products that include the OLED are also provided.

Abstract: Provided are organometallic compounds comprising a central metal atom which is coordinated by at least one ligand which is at least two-dentate and which comprises at least two 5-membered to 10-membered carbocyclic or heterocyclic rings. Also provided are formulations comprising these organometallic compounds. Further provided are organic light emitting devices (OLEDs) and related consumer products that utilize these organometallic compounds.